CSIMarket
 


Intercept Pharmaceuticals inc   (ICPT)
Other Ticker:  
 

Intercept Pharmaceuticals Inc 's Leverage Ratio

ICPT's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -22.96% Intercept Pharmaceuticals Inc improved Leverage Ratio in third quarter 2023 to 4.47, above the Intercept Pharmaceuticals Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 80 other companies have achieved lower Leverage Ratio than Intercept Pharmaceuticals Inc in the III Quarter 2023. While Leverage Ratio total ranking has improved so far in the third quarter 2023 to 1267, from total ranking in the second quarter 2023 at 3170 .

Explain Leverage Ratio?
Who are ICPT Customers?
What are ICPT´s Total Liabilities?


ICPT Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -33.28 % - - - -
Y / Y Total Liabilities Change -28.87 % -51.97 % -50.08 % -35.21 % -33.48 %
Leverage Ratio MRQ 4.47 6.17 6.5 4.95 4.2
ICPT's Total Ranking # 1267 # 3170 # 2630 # 1909 # 3203
Seq. Equity Change 6.36 % 0.54 % -27.82 % -13.56 % -
Seq. Total Liabilities Change -22.96 % -4.53 % -5.15 % 1.97 % -47.98 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 205
Overall Market # 1267


Leverage Ratio Statistics
High Average Low
28.56 3.99 0.04
(Dec 31 2017)   (Jun 30 2015)




Financial Statements
Intercept Pharmaceuticals Inc 's Equity $ 72 Millions Visit ICPT's Balance sheet
Intercept Pharmaceuticals Inc 's Total Liabilities $ 321 Millions Visit ICPT's Balance sheet
Source of ICPT's Sales Visit ICPT's Sales by Geography


Cumulative Intercept Pharmaceuticals Inc 's Leverage Ratio

ICPT's Leverage Ratio for the trailling 12 Months

ICPT Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -33.28 % - - - -
Y / Y Total Liabilities TTM Growth -28.87 % -51.97 % -50.08 % -35.21 % -33.48 %
Leverage Ratio TTM 5.46 5.27 - - -
Total Ranking TTM # 65 # 267 # 2636 # 2336 # 0
Seq. Equity TTM Growth 6.36 % 0.54 % -27.82 % -13.56 % -
Seq. Total Liabilities TTM Growth -22.96 % -4.53 % -5.15 % 1.97 % -47.98 %


On the trailing twelve months basis Despite of the repayements of liabilities of -22.96% in the trailing twelve months ending in III Quarter 2023, Leverage Ratio improved to 5.46, below Intercept Pharmaceuticals Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 26, during the past 12 months, other companies have achieved lower Leverage Ratio than Intercept Pharmaceuticals Inc . While Leverage Ratio total ranking has improved so far to 65, from total ranking in previous 12 month period at 267.

Explain Leverage Ratio?
Who are ICPT Customers?
What are ICPT´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 31
Within the Market # 65


trailing twelve months Leverage Ratio Statistics
High Average Low
40.54 5.89 0.06
(Jun 30 2020)   (Sep. 30, 2015)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Trevena inc   11.72 $ 41.584  Millions$ 3.549  Millions
Madrigal Pharmaceuticals Inc   9.61 $ 213.879  Millions$ 22.249  Millions
Iterum Therapeutics Plc  8.50 $ 29.165  Millions$ 3.432  Millions
Ionis Pharmaceuticals Inc  8.30 $ 2,618.511  Millions$ 315.460  Millions
Skye Bioscience Inc   8.20 $ 13.909  Millions$ 1.695  Millions
Abbvie inc   7.46 $ 90,439.000  Millions$ 12,129.000  Millions
Aravive Inc   6.67 $ 11.348  Millions$ 1.701  Millions
Collegium Pharmaceutical Inc   5.55 $ 992.321  Millions$ 178.873  Millions
Molecular Templates inc   5.48 $ 37.260  Millions$ 6.801  Millions
Arcutis Biotherapeutics Inc   5.27 $ 246.242  Millions$ 46.717  Millions
Clearmind Medicine Inc   5.05 $ 4.970  Millions$ 0.983  Millions
Innovation Pharmaceuticals Inc   4.74 $ 5.505  Millions$ 1.162  Millions
Amicus Therapeutics inc   4.73 $ 630.847  Millions$ 133.237  Millions
Unicycive Therapeutics Inc   4.72 $ 16.008  Millions$ 3.390  Millions
Teva Pharmaceutical Industries Limited  4.68 $ 35,158.000  Millions$ 7,512.000  Millions
Petros Pharmaceuticals inc   4.61 $ 31.982  Millions$ 6.933  Millions
Intercept Pharmaceuticals inc   4.47 $ 321.317  Millions$ 71.845  Millions
Blueprint Medicines Corporation  4.46 $ 902.688  Millions$ 202.611  Millions
Kala Bio inc   4.45 $ 49.897  Millions$ 11.223  Millions
Puma Biotechnology Inc   4.26 $ 164.863  Millions$ 38.742  Millions
Celularity Inc   4.20 $ 126.945  Millions$ 30.247  Millions
Mustang Bio inc   4.13 $ 16.558  Millions$ 4.009  Millions
Mersana Therapeutics Inc   4.04 $ 210.709  Millions$ 52.195  Millions
Vbi Vaccines Inc  3.88 $ 77.194  Millions$ 19.886  Millions
Biolinerx Ltd   3.83 $ 50.702  Millions$ 13.223  Millions
Aytu Biopharma Inc   3.13 $ 100.721  Millions$ 32.167  Millions
Sarepta Therapeutics Inc   3.04 $ 2,322.856  Millions$ 764.357  Millions
Eli Lilly And Company  2.94 $ 33,266.700  Millions$ 11,307.400  Millions
Harrow Inc   2.79 $ 210.308  Millions$ 75.402  Millions
Kineta Inc   2.77 $ 7.991  Millions$ 2.889  Millions

Date modified: 2023-11-07T12:02:43+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com